Cost-benefit or cost-utility analysis?

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.315, 2001-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

How Often Do Sensitivity Analyses for Economic Parameters Change Cost-Utility Analysis Conclusions?

By Schackman B.R.

PharmacoEconomics, Vol. 22, Iss. 5, 2004-01 ,pp. : 293-300

Adis International

Access to resources Recommend Favorite

The (Near) Equivalence of Cost-Effectiveness and Cost-Benefit Analyses: Fact or Fallacy?

By Donaldson C.

PharmacoEconomics, Vol. 13, Iss. 4, 1998-04 ,pp. : 389-396

Adis International

Access to resources Recommend Favorite

Validity of Cost and Utility Results?

By Diamantopoulos Alex

PharmacoEconomics, Vol. 30, Iss. 10, 2012-10 ,pp. : 977-977

Adis International

Access to resources Recommend Favorite

Calculating utility: preclinical evidence for cost–benefit analysis by mesolimbic dopamine

By Phillips Paul Walton Mark Jhou Thomas

Psychopharmacology, Vol. 191, Iss. 3, 2007-04 ,pp. : 483-495

Springer Publishing Company

Access to resources Recommend Favorite

Cost-Benefit Analysis of Amtolmetin-Guacil

By Belisari A. Mantovani L.G.

Clinical Drug Investigation, Vol. 21, Iss. 1, 2001-01 ,pp. : 47-58

Adis International

Access to resources Recommend Favorite